What does Novel Bioventures invest in?
Novel Bioventures invests most often at Series B and Series C (75% of the rounds on record).
United States · Investor
No cheque observed since May 2005, after 4 earlier cheques, and the website is dead.
DormantGrowth equity
4 rounds on record
Mostly Series B and Series C: 75% of its rounds
Every round we can evidence, newest first4 appearances
2 rounds
2 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The investors most often in the same rounds as Novel Bioventures. A count of rooms they were both in, not a relationship either has claimed.
Novel Bioventures invests most often at Series B and Series C (75% of the rounds on record).
4 investments on record, 0 of them in the last 12 months. The most recent was in May 2005.
The median round it joins is $35M.
It looks quiet: no investment on record since May 2005.
Most often MPM Capital (2 rounds together) and OrbiMed (2 rounds together).
Novel Bioventures is a growth equity firm based in United States.
From 2 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it